Several SURMOUNT studies in patients with obesity are ongoing ( In the SURPASS-1 study, which enrolled 705 non-target T2DM patients with diet and physical activity intervention, the efficacy, safety, and tolerability of tirzepatide and a placebo were compared
Statistical analyses The statistical test used for each panel, sidedness, multiple-testing correction and the corresponding sample size are stated in the relevant figure legend and in the Source Data file
With GLP-1 medication, we aim to empower individuals to take control of their weight and overall health, ultimately improving their quality of life
You recall feeling nauseous during the first week, and you might have had some problems with constipation , but you aren't sure if that was last week or two weeks ago
This is the practical question most people actually care about